IDENTIFICATION AND VALIDATION OF METHYLATION BIOMARKERS TO ASSESS RESPONSE TO THERAPY IN HORMONE RECEPTOR-NEGATIVE BREAST CANCER

The Johns Hopkins University

Investigators